- This event has passed.
ORAL RINSES: What’s Safe? What’s Effective?
August 21 @ 8:00 pm – 10:00 pm EDT
COURSE SUMMARY: This course will analyze the efficacy and safety of current oral rinses and introduce the latest generation of rinses under development. Upon the completion of this webinar, you will be provided with evidence-based studies showing the most effective rinses for both patients and staff.
LEARNING OBJECTIVES:
- Review the evolution of iodine in becoming a standard of care.
- Learn about a technological breakthrough leading to a new class of “super” iodines.
- Understand how the implementation of the new “super” iodines in your practice will benefit your patients.
- Compare the advantages and disadvantages of commonly used oral rinses.
- Describe the misconceptions related to iodine sensitivity.
- Learn why periodontal bacteremias are now considered a cause of cardiovascular disease.
INSTRUCTIONS: Following the Continuing Education webinar of 90 minutes duration, a brief promotional webinar concerning molecular iodine will be provided by the sponsor. You will be given the option to log off and be redirected to complete a quiz for CE Credit. In accordance with AGD PACE standards, you are not required to watch the optional promotional webinar to complete the course quiz/evaluation and obtain CE Credits.
INSTRUCTIONS: Dental CE Academy hosts all webinars using the Clickmeeting platform. Upon registration you are sent a confirmation email from no-reply@clickeeting.com with a link to join. Be sure to check your spam/junk/promotions folders. We recommend logging in 15 minutes early in the event you require assistance.
HANDOUTS: Distributed via email to all attendees 1 hour prior to start, during and after the webinar.
QUIZ FOR CE CREDIT VERIFICATION: At the conclusion of the webinar, attendees will be redirected to complete a quiz for CE credit. An 80% minimum passing score is required, multiple attempts are permitted, and attendees have 7 days to successfully complete the quiz for CE credit.
DISCLOSURE OF SPEAKER AND FACULTY COMMERCIAL RELATIONSHIPS: According to Dental CE Academy’s Conflict of Interest and Disclosure Policy, faculty and speakers for any course are expected to disclose any economic support, personal interests, or potential bias that may be perceived as creating a conflict related to the material being presented. Disclosure statements are printed in each course description and announced by moderators or individual speakers at the beginning of each presentation. This policy is intended to alert the audience to any potential bias or conflict so that participants may form their own judgments about the material being presented.
CONFLICT OF INTEREST AND FINANCIAL DISCLOSURE OF SPEAKER: Dr. Herb Moskowitz, DDS; is the Chairman and Co-Founder of ioTech International. He is a paid speaker and has a financial interest in ioTech International.
DENTAL CE ACADEMY DISCLAIMER: The views expressed and opinions and materials presented during these live and recorded presentations represent the personal views and opinions of the individual speaker and do not necessarily represent the views and opinions of Dental CE Academy or its parent company, Virtual Dontics®. Dental CE Academy assumes no responsibility for the content of the presentations made by the individual speakers. Any suggested protocols for treatment, materials, or services may be based upon the speaker’s own clinical experience and should not be construed as Dental CE Academy recommended or endorsed. Selected presentations may include exploratory research or experimental procedures and are intended for informational purposes that may lead to interest and scientific breakthroughs in the fields of dentistry. Dental CE Academy appreciates its educators who share their knowledge and expertise. This level of dedication to dentistry allows our profession to expand and thrive and provokes necessary discussion and understanding.
About the Speaker
Dr. Herb Moskowitz, DDS
Dr. Herb Moskowitz is the Chairman and Co-Founder of ioTech International. He is the co-author of ioTech’s U.S. patent and global patent applications. He previously founded and served as Chairman and CEO of Advanced Tissue Sciences and Life Medical Sciences, two publicly traded medical technology companies. He has also practiced clinical dentistry for more than 25 years and is a graduate of the University of Tennessee Dental School.
